Parkinson’s disease: Servier and Oncodesign announce the selection of a preclinical candidate
Initiated in March 2019, this Research and Development partnership is focused on the identification of LRRK2 kinase inhibitors derived from Oncodesign’s proprietary Nanocyclix® platform and their potential to act as therapeutic agents against Parkinson’s disease, drawing on Servier and Oncodesign’s complementary expertise in the field of neurodegenerative disease and kinase inhibitors.
Our values are integral to our soul, culture and reputation. They are aimed at all our communities and form a solid foundation on which our employees can rely in order to fulfill our mission.
SOLIDARITY by behaving responsibly and assisting each other in a reciprocal manner, by taking ownership of and joint responsibility for achieving individual and Group-wide objectives and delivering performance.
INGENUITY by showing imagination, skill and expertise: be capable of devising new possibilities, designing solutions, having original and inventive ideas.
VITALITY which means demonstrating considerable energy and drive, engaging in powerful and rewarding activities, which reflect the ability to develop and grow and to achieve results, adapt to changes intelligently, mirroring life itself.
RATIONAL APPROACH by acting consistently and logically, and by applying reason.
INTEGRITY by behaving honestly and fairly, striving for zero defects by adopting the highest possible standards.
If you share these values, join us – all that’s missing is you!